Systemic complications | Infected (N = 19) | Clear (N = 58) | Infected versus clear, P value | Relative risk [95% CI] |
---|---|---|---|---|
Complications per patient (pt) within 100 days | 0.9 ± 0.9 [0–3] | 0.9 ± 1 [0–4] | 0.99 | |
Complications per pt after 100 days | 0.9 ± 1.4 [0–6] | 0.9 ± 1.4 [0–6] | 0.99 | |
Fever | 9 (37%) | 12 (21%) | 0.27 | 2.4 [1.4–5.1] |
Within 100 days | 6 (26%) | 5 (10%) | 0.03 | 3.6 [0.9–4.7] |
After 100 days | 3 (16%) | 7 (12%) | 0.97 | 1.31[0.4–3.2] |
Pneumonia | 4 (21%) | 1 (2%) | 0.02 | 3.8 [2.1–7.2] |
Within 100 days | 2 (11%) | 1 (2%) | 0.15 | 2.9 [1.2–7.2] |
After 100 days | 2 (11%) | 0 (0%) | 0.06 | 4.4 [2.9–6.7] |
Urinary tract infections | 9 (47%) | 34 (58%) | 0.27 | 0.7 [0.3–1.5] |
Within 100 days | 6 (32%) | 20 (34%) | 0.52 | 0.9 [0.4–1.9] |
After 100 days | 3 (16%) | 14 (24%) | 0.34 | 0.6 [0.2–2] |
Systemic infections | 4 (21%) | 11 (17%) | 0.56 | 1.1 [0.4 – 2.8] |
Within 100 days | 3 (16%) | 7(12%) | 0.47 | 1.3 [0.4–4.6] |
After 100 days | 1 (5%) | 4 (7%) | 0.64 | 0.8 [0.09–6.4] |
Rejection | 1 (19%) | 3 (5%) | 0.69 | 1.0 [0.1–9.2] |
Within 100 days | 0 | 2 (3%) | 0.57 | |
After 100 days | 1 (5%) | 1 (2%) | 0.44 | 3.1 [0.2–46] |